The Henan Broadhi Biological Fund was established with 250 million RMB ($40 million) of venture capital to support biological companies in Henan Province; ShanghaiTech University announced the formation of the iHuman Institute, an international basic science research effort that will focus on cell signaling and kinases; Hebei Changshan Biochemical Pharma will form a JV with ConjuChem, a privately owned Los Angeles company that is developing a long-acting form of insulin; Sihuan Pharma, China’s largest cerebral-cardiovascular drugmaker, bought China rights to two clinical-stage drugs from NeuroVive Pharmaceutical; and Hua Medicine is on track to start clinical trials of a treatment for type 2 diabetes in-licensed from Roche. More details…. Stock Symbols: (SHE: 300255) (HK: 0460) (SIX: ROG) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});